Remove tag vector
article thumbnail

Upcoming sickle cell gene therapies cost effective at $2 million, says ICER

Pharmaceutical Technology

Although the findings in the report are only preliminary, they shed light at the considerations behind the high price tags of gene therapies. Bluebird already uses a lentiviral vector in its approved gene therapy for beta-thalassemia called Zynteglo. Also known as lovo-cel, bluebird bio’s product is a lentiviral gene therapy.

article thumbnail

Uncovering the Hidden Gems within Your Datasets

PM360

Additionally, newly launched vector databases made it simple to store semantic representation of data known as embeddings, which coupled with retrieval-augmented generation made it easy to find documents relevant to a query from massive data assets in seconds. “To

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Leading innovators in peptide nano-particle conjugates for the pharmaceutical industry

Pharmaceutical Technology

Adeno-associated virus vectors, alcohol dehydrogenase compositions, and antibody serum stabilisers are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are anti-influenza antibody compositions and anti-interleukin-1, which are now well established in the industry.

article thumbnail

Roctavian okay sets up another gene therapy test for Europe

pharmaphorum

Roctavian delivers a working copy of the Factor VIII gene into cells via an adeno-associated virus (AAV) vector, and offers a one-shot, potentially curative therapy for haemophilia A. million spread over five years.

FDA 111
article thumbnail

Putting complex medicines under the microscope

European Pharmaceutical Review

BT-474 cell line was gene-edited to incorporate a green fluorescent protein (GFP) tag into late endosomes/lysosomes (green). Her expertise lies in developing cellular models by applying genetic engineering techniques, including viral vectors and CRISPR/Cas. Physical characterisation. During her PhD at St.

Medicine 102
article thumbnail

Dedi Gilad

Cadensee

But I would say in general, the basic vector of our development was not changed meaningfully because of the COVID. It's already tagged by clinicians with the diagnosis, so you have to do the machine learning and the engineering side. We also saw a big growth in you know, demand and manufacturing. Chen: Sure.